Medicure (MCUJF) EPS (Basic) Growth (3y) (2012 - 2026)
Medicure (MCUJF) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | 7.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.37% |
| Dec 31, 2025 | -54.82% |
| Sep 30, 2025 | -47.21% |
| Jun 30, 2025 | -43.90% |
| Mar 31, 2025 | 14.71% |
| Dec 31, 2024 | 32.03% |
| Sep 30, 2024 | -15.89% |
| Jun 30, 2024 | -60.63% |
| Mar 31, 2024 | 26.93% |
| Dec 31, 2023 | 46.79% |
| Sep 30, 2023 | 27.72% |
| Jun 30, 2023 | 528.32% |
| Mar 31, 2023 | 29.94% |
| Dec 31, 2022 | 32.74% |
| Sep 30, 2022 | 68.01% |
| Jun 30, 2022 | 6.51% |
| Mar 31, 2022 | 30.15% |
| Dec 31, 2021 | -89.48% |
| Sep 30, 2021 | 426.16% |
| Jun 30, 2021 | 211.24% |